About Harmony test

Since its introduction in 2012, the Harmony non-invasive prenatal test (NIPT) has emerged as one of the pioneering options in prenatal screening tests. Supported by Roche's long-standing dedication and over 125 years of service, the Harmony test provides the accuracy and reliability you have come to expect from Roche products. Moreover, it is the most extensively studied NIPT available, proven to surpass traditional screening methods with exceptional performance.¹

Roche has been a trusted healthcare pioneer for over 125 years. As a front-runner in personalized healthcare and in-vitro diagnostics, Roche drives innovation and advancements in these fields. As the world’s leading biotechnology company, Roche is proud to be entrusted with 100,000 instrument placements² and 27 billion tests annually worldwide.² These achievements are made possible by a dedicated team of over 101,000 employees³ across more than 100 countries worldwide.²

 

Trusted by patients worldwide, the Harmony test is available in more than 100 countries and used in more than 2 million pregnancies.⁴ It stands as the most extensively studied cell-free DNA test in the market, with more than 330,000 patient samples included in over 78 peer-reviewed publications.⁵ In comparison to traditional screening tests like first-trimester screening, the Harmony test offers enhanced accuracy and a lower false positive rate , providing you and your patients with peace of mind and confidence in first-line screening results.¹